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B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for
establishing long-lived antibody responses in humans
Abstract
Engagement of cytokine receptors by specific ligands activate Janus kinase-signal transducer and
activator of transcription (STAT) signaling pathways. The exact roles of STATs in human lymphocyte
behavior remain incompletely defined. Interleukin (IL)-21 activates STAT1 and STAT3 and has emerged as
a potent regulator of B cell differentiation. We have studied patients with inactivating mutations in STAT1
or STAT3 to dissect their contribution to B cell function in vivo and in response to IL-21 in vitro. STAT3
mutations dramatically reduced the number of functional, antigen (Ag)-specific memory B cells and
abolished the ability of IL-21 to induce naive B cells to differentiate into plasma cells (PCs). This resulted
from impaired activation of the molecular machinery required for PC generation. In contrast, STAT1
deficiency had no effect on memory B cell formation in vivo or IL-21-induced immunoglobulin secretion in
vitro. Thus, STAT3 plays a critical role in generating effector B cells from naive precursors in humans.
STAT3-activating cytokines such as IL-21 thus underpin Ag-specific humoral immune responses and
provide a mechanism for the functional antibody deficit in STAT3-deficient patients.
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Engagement of cytokine receptors by specific ligands activate Janus kinase–signal transducer
and activator of transcription (STAT) signaling pathways. The exact roles of STATs in human
lymphocyte behavior remain incompletely defined. Interleukin (IL)-21 activates STAT1 and STAT3
and has emerged as a potent regulator of B cell differentiation. We have studied patients with
inactivating mutations in STAT1 or STAT3 to dissect their contribution to B cell function in vivo
and in response to IL-21 in vitro. STAT3 mutations dramatically reduced the number of functional, antigen (Ag)-specific memory B cells and abolished the ability of IL-21 to induce naive
B cells to differentiate into plasma cells (PCs). This resulted from impaired activation of the
molecular machinery required for PC generation. In contrast, STAT1 deficiency had no effect
on memory B cell formation in vivo or IL-21–induced immunoglobulin secretion in vitro. Thus,
STAT3 plays a critical role in generating effector B cells from naive precursors in humans.
STAT3-activating cytokines such as IL-21 thus underpin Ag-specific humoral immune responses
and provide a mechanism for the functional antibody deficit in STAT3-deficient patients.
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exhibit poor Ag-specific Ab responses after immunization
with T cell–dependent (TD) Ag (Dreskin et al., 1985; Leung
et al., 1988; Sheerin and Buckley, 1991). Consequently,
they suffer from an increased incidence of infections with
encapsulated organisms (Streptococcus pneumoniae, Haemophilus
influenzae), a scenario consistent with a B cell defect manifesting
as functional Ab deficiency (Dreskin et al., 1985; Leung et al.,
1988; Sheerin and Buckley, 1991).
The mechanisms underlying some of the clinical features
of AD-HIES are being unraveled. Elucidation of the T cell–
intrinsic actions of STAT3 revealed that the unique susceptibility of these patients to infections at epithelial surfaces is
caused by a deficiency of Th17 cells (de Beaucoudrey et al.,
2008; Ma et al., 2008; Milner et al., 2008; Renner et al.,
2008; Minegishi et al., 2009). These studies highlighted the
utility of analyzing lymphocyte differentiation in patients
with defined molecular lesions as a strategy of understanding
key clinical features of immunodeficient conditions. Despite
this progress, the mechanism underlying reduced Ag-specific
Ab responses, despite normal serum Ig levels, in patients with
STAT3 mutations is unknown. Thus, it is of considerable interest to understand the B cell–intrinsic function of STAT3.
Studies of gene-modified mice and of human B cells in
vitro have revealed that IL-21 is a key cytokine for establishing, maintaining, and regulating the quality of Ab responses
(Ozaki et al., 2002; Ozaki et al., 2004; Pène et al., 2004;
Bryant et al., 2007; Avery et al., 2008a,b; Ettinger et al., 2008;
Nurieva et al., 2008; Vogelzang et al., 2008). IL-10 is also
capable of inducing Ig secretion from human B cells, albeit to
a much lesser extent than IL-21 (Rousset et al., 1992; Brière
et al., 1994; Bryant et al., 2007). Importantly, these cytokines
are capable of activating STAT3 (Asao et al., 2001; Habib
et al., 2002; Zeng et al., 2007; Diehl et al., 2008). Based on this,
we hypothesized that impaired responsiveness to IL-10 and
IL-21 may account for the functional Ab deficiency in ADHIES patients. We found that STAT3 plays a critical role in
generating memory cells and plasma cells (PCs) from naive
precursors in vivo and in vitro in response to IL-10 and IL-21.
This function of STAT3 is nonredundant because similar defects
were not observed in the context of mutations in STAT1.
This reveals that STAT3-activating cytokines, predominantly
IL-21, are key mediators of human B cell effector function
and humoral immune responses, and importantly, provides a
mechanism for the functional Ab deficit in AD-HIES patients.
RESULTS
IL-21 predominantly activates STAT1 and STAT3
in primary human B cells
IL-21 can activate STAT1, STAT3, and STAT5, and the
mitogen-activated protein kinase and Akt pathways (Asao
et al., 2001; Zeng et al., 2007; Diehl et al., 2008). To extend
these studies, human splenic B cells were stimulated with
CD40L and anti-Ig for 24 h and then exposed to IL-21.
STAT1 and STAT3 became maximally phosphorylated
within 15–30 min of IL-21 exposure and returned to basal
levels by 60 min (Fig. 1, A and B). In contrast, there was only
STAT3 deficiency impairs B cell differentiation | Avery et al.
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Human antibody (Ab) deficiency disorders are the most
common form of primary immunodeficiency (CunninghamRundles and Ponda, 2005; Fischer, 2007). Many of these
patients have absolute deficiency of serum Ig and are diagnosed
with common variable immunodeficiency (CVID). Interestingly, individuals with normal serum IgG can nonetheless experience recurrent invasive infections with encapsulated organisms
or have defects in establishing antigen (Ag)-specific Ab responses (Cunningham-Rundles and Ponda, 2005; Fischer, 2007).
These clinical observations indicate that intrinsic functional B
cell defects have significant consequences for host defense,
even though they may not manifest as hypogammaglobulinemia.
With the exception of the hyper-IgM syndromes caused
by mutations in CD40, AICDA, and UNG (CunninghamRundles and Ponda, 2005), we have very little insight into the
mechanisms underlying these intrinsic B cell defects.
Differentiation of naive lymphocytes into effector cells is
regulated in part by signals delivered through cytokine receptors and subsequent activation of JAK–STAT signaling pathways (Akira, 1999; Shuai and Liu, 2003; O’Shea and Murray,
2008). Four JAK and seven STAT proteins have been identified,
and germline or conditional deletion has revealed important
roles for specific JAK–STAT pathways in the development
and differentiation of multiple cell lineages (Akira, 1999; Shuai
and Liu, 2003; O’Shea and Murray, 2008). Furthermore,
mutations in JAK3, TYK2, STAT1, and STAT5B are associated with human immunodeficiencies (Macchi et al., 1995;
Dupuis et al., 2003; Bernasconi et al., 2006; Minegishi et al.,
2006; Fischer, 2007), underscoring the fundamental role of
these molecules in immune regulation.
Recently, heterozygous mutations in STAT3 have been
found to cause 60% of cases of autosomal dominant hyperIgE syndrome (AD-HIES; Holland et al., 2007; Minegishi
et al., 2007). Most mutations act in a dominant-negative
(DN) manner, reducing the number of functional STAT3
dimers by 75% (Minegishi et al., 2007). In contrast to all
other STATs, germline deletion of Stat3 is embryonically
lethal (Akira, 1999). Thus, although residual functional
STAT3 dimers in AD-HIES allow placental development,
they are insufficient to prevent disease. Because STAT3 is
widely expressed and activated by >25 cytokines (O’Shea
and Murray, 2008; Tangye et al., 2009), it is not surprising
that AD-HIES is a multisystem disease affecting the immune
and musculoskeletal systems. Immunological defects include
skin lesions (eczema, boils), recurrent invasive mucocutaneous and lung infections with Staphylococcus aureus and Candida albicans, and high levels of IgE (Davis et al., 1966;
Grimbacher et al., 2005; Tangye et al., 2009). The dysregulation underlying increased serum IgE in AD-HIES patients
remains to be established. It does not appear to result from
an intrinsic B cell defect that results in enhanced switching
to IgE (Avery et al., 2008b) but may reflect altered production of regulatory cytokines by CD4+ T cells (Ma et al.,
2008) and defects at epithelial surfaces (Grimbacher et al.,
2005; Tangye et al., 2009). Although AD-HIES patients
have normal serum levels of IgM, IgG, and IgA, many
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a low level of phospho-STAT5 detected in IL-21–stimulated
human B cells and no difference in the phosphorylation status
of STAT6 in B cells cultured with or without IL-21 (Fig. 1,
A and B). Thus, IL-21 predominantly activates STAT1 and
STAT3 in human B cells.

STAT3 deficiency impairs the in vivo generation
of human memory B cells in AD-HIES patients
The ability of IL-21 to activate STAT1 and STAT3, and the
important role of IL-21 in regulating B cell responses (Ozaki
et al., 2002; Pène et al., 2004; Bryant et al., 2007; Avery
et al., 2008a,b; Diehl et al., 2008; Ettinger et al., 2008)
suggested that patients with STAT1 or STAT3 mutations
may have defects in B cell differentiation in vivo. Thus, we
examined the generation of memory cells in these patients.
Human B cells can be resolved into subsets of transitional, naïve, and memory cells by the differential expression
of CD10 and CD27. In normal donors, 15% of peripheral
blood (PB) lymphocytes are B cells; 10% of these are
JEM VOL. 207, January 18, 2010

STAT3MUT AD-HIES patients fail to generate
Ag-specific effector B cells
The importance of STAT3 in generating memory B cells is
consistent with previous findings of defective functional
Ab responses in AD-HIES patients (Dreskin et al., 1985;
Leung et al., 1988; Sheerin and Buckley, 1991). One caveat
of these studies is that they predated the discovery that
STAT3 mutations caused this condition. Thus, the molecular
lesion in the patients studied was unknown. This is particularly relevant because STAT3 mutations cause AD-HIES
157
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STAT1 and STAT3 mutant patients
To dissect the molecular mechanism whereby IL-21 activates
human B cells, we analyzed B cell development and effector
function in individuals with mutations in STAT1 or STAT3.
We studied 10 patients with STAT3 mutations. All had
aberrantly high levels of serum IgE, a Th17 deficiency, and
heterozygous mutations in the DNA-binding, Src homol
ogy 2, or transactivation domains of STAT3 (Table S1; Ma
et al., 2008). We also examined six patients who had either
homozygous (Chapgier et al., 2006b; Chapgier et al., 2009) or
heterozygous DN mutations (Dupuis et al., 2001; Chapgier
et al., 2006a) in STAT1 (Table S2).
We examined IL-21–induced STAT phosphorylation in
EBV-transformed lymphoblastoid cell lines (EBV-LCLs)
from patients with heterozygous mutations in STAT3 (n = 5),
complete STAT1 deficiency (n = 3; Dupuis et al., 2003;
Chapgier et al., 2006b), or partial STAT1 deficiency with
homozygous (n = 1; Chapgier et al., 2009) or heterozygous
(n = 4; Dupuis et al., 2001; Chapgier et al., 2006a) STAT1
mutations. Stimulation of normal LCLs with IL-21 resulted
in robust phosphorylation of both STAT1 and STAT3 (Fig. 1,
C and D). STAT1 and STAT3 were also phosphorylated in
IL-21–stimulated LCLs from STAT3 mutant (STAT3MUT)
patients, irrespective of the location of the STAT3 mutation,
or patients with DN STAT1 mutations, with the levels
falling within the ranges established for normal LCLs (Fig. 1
D and Fig. S1). IL-21 also activated STAT3 in LCLs from
patients who lacked STAT1 (Fig. 1, C and D). Because of the
deficiency of STAT1 in these cell lines, no phospho-STAT1
was detected. IL-21 induced only modest phospho-STAT5
in normal and STATMUT LCLs, whereas it did not activate
STAT6 in any of these LCLs (Fig. 1 C, D). Thus, consistent
with the findings by us (Fig. 1, A and B) and others (Diehl
et al., 2008) for primary human B cells, IL-21 predominantly
activates STAT1 and STAT3 even in the presence of mutations in these signaling molecules.

transitional (CD10+CD27), whereas 25–35% are memory
(CD27+; Fig. 2, A–C; Klein et al., 1998; Tangye et al., 1998;
Wardemann et al., 2003; Ma et al., 2005; Ma et al., 2006;
Avery et al., 2008b). Within the CD27+ B cell population of
normal donors (5–65 yr old), 50, 25, and 20% of them
express IgM, IgG, or IgA, respectively (Fig. 2 D; Ma et al.,
2005; Ma et al., 2006). Analysis of 10 STAT3MUT and 6
STAT1MUT patients demonstrated no significant difference
(P > 0.05) in the frequencies of total PB B cells compared
with normal controls (Fig. 2 A). However, the frequencies
of transitional and naive cells were increased and memory
cells were dramatically reduced (P < 0.01; Fig. 2, B and C)
in STAT3MUT patients compared with healthy donors. The
defect in memory cell generation was observed for all
patients examined irrespective of their STAT3 mutation, in
contrast to patients with elevated serum IgE levels but WT
STAT3, or patients with STAT1 mutations—who had normal frequencies of B cell subsets (Fig. 2, A–C)—and a large
cohort of CVID patients, of whom 50% had a memory
B cell deficit (Fig. 2 C). We also detected normal percentages
of IgG+ memory cells (32.1 ± 4.7%; range: 24.5–45.4%) in
STAT1MUT patients (n = 5), suggesting that memory B cell
generation is normal in these individuals. Thus, intact signaling through STAT3 is required to generate the memory
B cell pool, whereas signaling through STAT1 is dispensable
for memory B cell formation.
Notably, the distribution of nonswitched and switched
B cells within the CD27+ subset from normal donors and
STAT3MUT patients was similar, with 50% expressing IgM
and 40% having undergone switching to express IgG or
IgA (Fig. 2 D). There was a significant increase and decrease
in the frequencies of IgG+ and IgA+ memory cells, respectively, in STAT3MUT patients compared with healthy controls (Fig. 2 D). Because B cells need to undergo greater
rounds of proliferation to switch to IgA than they do for IgG
(Deenick et al., 1999; Avery et al., 2008a), these differences
in frequencies of IgG+ and IgA+ memory B cells may reflect
in vivo defects in the proliferation of STAT3MUT B cells (see
Proliferation and survival induced by...). These phenotypic
features of memory B cells from STAT3MUT patients starkly
contrast patients with mutations in CD40LG, CD40, IKBKG,
ICOS, or SH2D1A, whose few memory B cells fail to undergo
isotype switching (Tangye and Tarlinton, 2009), and CVID
patients who display great heterogeneity in the nature of the
Ig isotype expressed by their cells (Fig. 2 D).
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Figure 1. IL-21 predominantly activates STAT1 and STAT3 in primary human B cells. (A and B) Human splenic B cells were cultured for 24 h with
CD40L plus anti-Ig and then cultured in the absence (red) or presence (blue) of IL-21. Phosphorylation of STAT1, 3, 5, and 6 was determined by intracellular staining. (A) Expression of phospho-STATs after 30 min. (B) Kinetics of IL-21–induced STAT phosphorylation in primary human B cells. These results are representative
of two (STAT5 and 6) or three (STAT1 and 3) experiments. (C) Expression of phospho-STATs in EBV-LCLs from normal controls or patients with mutations in STAT3
or STAT1 that were cultured without (red) or with (blue) IL-21 for 30 min. (D) Induction of phospho-STATs in cell lines examined from the indicated number of
normal donors (red squares) and STAT3MUT (black triangles, Src homology 2 domain mutations; blue triangles, DNA-binding domain mutations; green triangles,
transactivation domain mutations) and STAT1MUT patients (orange circles) in response to IL-21. The values represent the fold increase in mean fluorescence intensity of cells stimulated with IL-21 for 30 min over unstimulated cells. The symbols correspond to the mean derived from one to four experiments performed on
each cell line; the horizontal bars represent means. The dashed lines indicate a fold change of 1, which represents no change in expression of phospho-STAT
proteins in the presence of IL-21. DNABD, DNA-binding domain; MFI, mean fluorescence intensity; SH2, Src homology 2 domain; TA, transactivation domain.
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in only 60% of patients (Minegishi et al., 2007). Moreover,
there is some controversy regarding the appropriate criteria
by which human B cells are categorized as memory cells
(Tangye and Tarlinton, 2009). Thus, to confirm a role for

STAT3 mutations in causing a functional memory B cell and
Ab deficiency, we assessed Ag-specific B cell responses in our
cohort of STAT3MUT patients by adopting an approach that
made no assumptions about the phenotype of memory cells.

Downloaded from jem.rupress.org on January 19, 2010

Figure 2. Mutations in STAT3 severely compromise the generation of memory B cells. (A–C) The frequencies of total B cells (A) or transitional
(CD20+CD10+CD27), naive (CD20+CD10CD27), and memory (CD20+CD10CD27+) B cells (B and C) in healthy donors (HD; n = 26–32), STAT3MUT
patients (n = 10), patients with AD-HIES but WT STAT3 alleles (HIES; n = 4–5), STAT1MUT patients (n = 5–6), or CVID patients (n = 36) were determined by
flow cytometry. The values in B correspond to the frequencies (means ± SEM) of transitional (T), naive (N), and memory (M) B cells in the indicated donor
populations. (D) memory (CD20+CD10CD27+) B cells from healthy donors (HD; n = 32), STAT3MUT patients (n = 10), WT STAT3 AD-HIES patients (n = 5),
and CVID patients (n = 31) were labeled with mAbs specific for IgM, IgG, or IgA. The frequency of memory B cells that were IgM+, IgG+, or IgA+ was then
determined. The plots in A and B are from representative healthy donors and patients; the graphs in A, C, and D show data points for all donors and
patients examined, and the horizontal bars represent means. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
JEM VOL. 207, January 18, 2010
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more specific Ag (Fig. 3 F). Thus, production of high titer
and high-affinity Ag-specific Ig requires intact signaling
through STAT3.
Proliferation and survival induced by IL-10 and IL-21
is compromised in STAT3MUT naive B cells
To better understand how mutations in STAT3, but not
STAT1, might compromise the generation of both memory
cells and PCs, the functional consequences of such loss-offunction mutations on the responses of human B cells in vitro
were investigated. We first examined the ability of IL-21
to augment proliferation of naive control, STAT3MUT, and
STAT1MUT B cells induced by CD40L, as revealed by CFSE
dilution over a 5-d culture. We also investigated responses to
IL-10, because it activates STAT3 and enhances human B
cell proliferation and differentiation, although to a much
lesser extent than IL-21 (Fig. S1; Rousset et al., 1992; Leonard,
2001; Bryant et al., 2007; Ettinger et al., 2008; O’Shea and
Murray, 2008). IL-4 was also examined as it predominantly
activates STAT6 (Leonard, 2001).
Naive B cells from healthy donors and STAT3MUT and
STAT1MUT patients exhibited identical proliferative responses after stimulation with CD40L alone or CD40L/IL-4
(Fig. 4, A and B). In contrast, expansion of CD40L-stimulated
STAT3MUT and STAT1MUT B cells to IL-10 and/or IL-21

Figure 3. STAT3 deficiency impairs the generation of Ag-specific memory B cells in vivo. B cells from healthy controls or STAT3MUT patients
were cultured with CD40L, CpG, SAC, IL-10, and IL-21 for 4 d and were recultured for 3 d. The proportion of cells secreting (A) IgM+IgG or (C) anti
tetanus IgG was determined by ELISPOT. (B) Levels of total Ig (IgM+IgG+IgA) secreted during the secondary culture were determined by ELISAs; the results
are expressed as micrograms of Ig secreted per 105 input cells in the secondary culture. Each symbol represents the response from an individual control or patient; the horizontal bars represent means. (D and E) Levels of antitetanus IgG in culture supernatants (Sn; D) or serum (E) from normal
controls or STAT3MUT patients were determined by ELISA. (F) Sera from controls or STAT3MUT patients (1:40 dilution) were incubated with decreasing
amounts of immobilized tetanus toxoid. Binding of antitetanus IgG was determined by ELISA. The results are expressed as the percentage of maximum
binding, which is defined as the binding to the highest concentration of tetanus (i.e., 3 µg/ml). In D, the data for the controls represent means ± SEM
from eight control donors; each blue line represents data from an individual STAT3MUT patient (n = 8). The data in E and F represent means ± SEM from
four control donors and five STAT3MUT patients.
160
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Total B cells were cultured with CD40L, CpG, S. aureus Cowan I (SAC; to engage the BCR), IL-10, and IL-21
for 4 d and recultured for another 3 d. The frequencies of
cells secreting IgM, IgG, or antitetanus IgG were then
determined. This assay relies on the in vitro differentiation
of Ag-specific memory B cells into Ig-secreting cells (ISCs).
Under these conditions, 10–15% of control B cells differentiated into ISCs (Fig. 3 A) and produced substantial
quantities of Ig during the secondary culture (Fig. 3 B).
Furthermore, the IgG-ISCs contained a detectable population of tetanus-specific B cells (Fig. 3 C). Although
STAT3MUT B cells also yielded polyclonal ISCs, the frequency and amount of Ig secreted was approximately threeto sixfold less than control B cells (Fig. 3, A and B).
Moreover, we were unable to detect Ag-specific cells in
any of the STAT3MUT patients examined (Fig. 3 C). We
also measured antitetanus IgG secreted by cultured B cells.
The levels of tetanus-specific IgG produced by control B
cells exceeded STAT3MUT B cells by >30-fold (Fig. 3 D).
This correlated with reduced levels of these Abs in the serum
of STAT3MUT patients (Fig. 3 E). When the relative affinity
of antitetanus IgG in the sera of controls and STAT3MUT
patients was compared, the half-maximal binding of control
sera to immobilized tetanus occurred at 100 ng/ml tetanus, whereas STAT3MUT sera required at least 10-fold
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was reduced (Fig. 4, A and B). Despite the reduced proliferation of STAT3MUT and STAT1MUT B cells to IL-10 or
IL-21, the extent of cell division induced by these cytokines

exceeded that of CD40L alone. Thus, loss of STAT1 and
STAT3 function compromises the proliferation-enhancing
effects of IL-10 and IL-21 on CD40L-stimulated B cells.
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Figure 4. Mutations in STAT3 or STAT1 partially reduce IL-10– and IL-21–mediated proliferation and survival of CD40L-activated B cells.
(A and B) Naive B cells were sort purified from healthy controls, STAT3MUT patients, or a STAT1MUT patient; labeled with CFSE; and cultured for 5 d with
CD40L alone or together with IL-4, IL-10, or IL-21. (A) CFSE profiles of control and STAT3MUT naive B cells stimulated under the indicated conditions.
(B) Frequency of B cells in each division; the values for the control and STAT3MUT B cells represent means ± SEM from five independent experiments. Data for
STAT1MUT B cells are from a single experiment. (C and D) Naive B cells from healthy controls or STAT3MUT patients were cultured for 3 d with CD40L alone
or together with IL-10 or IL-21. (C) The percentage of apoptotic cells was determined by annexin V staining. The values represent the mean percentage of
annexin V+ cells. (D) The number of viable cells recovered from each culture was also determined. (E and F) Expression of IL-10R (red; E) and IL-21R (red; F)
on naive B cells was determined by flow cytometry. The overlays (blue) represent isotype control mAb. The values are means ± SEM (n = 4) of the fluorescence
intensity of cells labeled with the isotype control or anti–IL-10R or –IL-21R mAb.
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Figure 5. Isotype switching, AICDA expression, and SHM are unaffected by mutations in STAT3 or STAT1. Naive B cells from (A) normal controls, (B) STAT3MUT patients, or (C) a STAT1MUT patient were labeled with CFSE; cultured for 5 d with CD40L alone or together with IL-4, IL-21, or IL-4/IL-21;
and analyzed for division and expression of surface IgG. A–C depict contour plots from one experiment. (D) Frequency of IgG+ (±SEM) cells in each
division (control and STAT3MUT: n = 7; STAT1MUT: n = 1). (E) Naive B cells from healthy controls or STAT3MUT or STAT1MUT patients were cultured with CD40L
alone or with IL-21. After 5 d, expression of AICDA was determined by quantitative PCR. The results are means ± SEM (control: n = 12; STAT3MUT: n = 7; or
162
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IL-21–induced isotype switching to IgG is unaffected
by mutations in STAT3 or STAT1
Although total memory cells were decreased in STAT3MUT
patients, the finding that the proportion of IgG+ and IgA+
cells within their memory compartment approximated normal
donors suggested that isotype switching occurred normally
in vivo despite mutations in STAT3. Because IL-10 and IL-21
can induce switching to IgG (Brière et al., 1994; Pène et al.,
2004; Avery et al., 2008a; Ettinger et al., 2008) and the effect
of IL-21 is enhanced by IL-4 (Avery et al., 2008a), we tested
whether naive STAT3MUT and STAT1MUT B cells could switch
to IgG in response to IL-10, IL-21, and/or IL-4. Although
CD40L had no effect on isotype switching by control B cells,
addition of IL-4 or IL-21 generated comparable frequencies
(3–5%) of IgG+ cells, and this frequency was increased
approximately four- to fivefold by the combination of IL-4
plus IL-21 (Fig. 5 A; Tangye et al., 2002; Avery et al., 2008a).
CD40L-stimulated naive STAT3MUT B cells also underwent
isotype switching to IL-4 and IL-21 alone or in combination
(Fig. 5 B). However, approximately two- to threefold fewer
IgG+ cells were generated compared with control naive B
cells (Fig. 5 B). In contrast, STAT1MUT B cells yielded normal

frequencies of IgG+ B cells (Fig. 5 C). IL-10 induced few
normal or STAT3MUT naive B cells to switch to IgG (Fig. S2,
A and B; Tangye et al., 2002). This was consistent with a
lack of induction of phospho-STAT1 and reduced phosphoSTAT3 (Fig. S1), and proliferation (Fig. 4, A and B) in IL-10–
stimulated B cells compared with IL-21. Thus, it was difficult
to ascertain whether isotype switching induced by IL-10 was
compromised by STAT3 mutations.
Ig isotype switching is linked to cell division (Hodgkin
et al., 1996; Deenick et al., 1999; Tangye et al., 2002). Because
there was a profound defect in proliferation of naive STAT3MUT
B cells to IL-21 (Fig. 4, A and B), it was important to investigate isotype switching in the context of cell division. CD40L/
IL-4 or CD40L/IL-4/IL-21 induced fewer (25–40%)
switched B cells per division from STAT3MUT B cells compared with normal B cells, suggesting that STAT3 plays a role
in IL-4–induced switching to IgG (Fig. 5 D). This is likely
because of the ability of IL-4 to activate STAT3 in human B
cells via the IL-4R–IL-13R1 complex, which functions
as the IL-13R as well as an alternative IL-4R (UmeshitaSuyama et al., 2000). In contrast, the division-based rate of
isotype switching by STAT3MUT B cells in response to
CD40L/IL-21 was similar to normal B cells (Fig. 5 D). Thus,
the reduced frequency of IgG+ cells generated from STAT3MUT
B cells as detected at the bulk population resulted from the
cells undergoing fewer rounds of division. Not surprisingly,
the division-based rate of switching of STAT1MUT B cells in
response to IL-4 and IL-21 was intact (Fig. 5 D).
The observations of normal isotype switching by STAT3MUT
and STAT1MUT B cells in vivo and in vitro prompted us to
examine expression of AICDA, which is required for isotype
switching (Muramatsu et al., 2000). IL-21 increased AICDA
expression in CD40L-stimulated normal, STAT3MUT, and
STAT1MUT naive B cells by 5–10-fold compared with that
induced by CD40L alone (Fig. 5 E). In contrast, IL-10 failed to
induce AICDA expression in normal and STAT3MUT naive B
cells (Fig. S2 C).Thus, IL-21–induced expression of AICDA and
subsequent class switching can occur despite impaired signaling through STAT1 or STAT3.
STAT3MUT memory B cells undergo somatic hypermutation
(SHM) in vivo
AICDA is also required for SHM (Muramatsu et al., 2000).
Thus, we assessed SHM in the few memory cells detectable
in STAT3MUT patients. Most Ig VH5 genes isolated from
normal (18 out of 19; 94.7%) and STAT3MUT (24 out of 26;
92.3%) naive B cells contained zero to one mutations (normal:
0.52 ± 0.14; STAT3MUT: 0.35 ± 0.14; Fig. 5 F), and 14 out
of 15 VH5 gene sequences from normal memory B cells
harbored mutations (5.1 ± 1.04 mutations/sequence; Fig. 5,
F and G). In contrast, only 13 out of 23 (56.5%) VH5 gene

STAT1MUT: n = 3 experiments) and are expressed relative to GAPDH. (F and G) Naive and memory B cells were isolated from three healthy donors and three
STAT3MUT patients. Ig VH5 genes were cloned and sequenced. (F) The number of mutations detected in each Ig VH5 gene isolated from normal and STAT3MUT
naive and memory B cells; the horizontal bars represent means. (G) Distribution of mutations in IgV region genes in control and STAT3MUT memory B cells.
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STAT3-activating cytokines can promote B cell survival
in vitro (Levy and Brouet, 1994; Otero et al., 2006). Thus,
we were interested in determining whether such prosurvival
effects were affected by STAT3 mutations. Naive B cells
were cultured with CD40L alone or together with IL-10 or
IL-21, and the level of apoptosis and the number of surviving
cells were determined after 3 d. Fewer STAT3MUT B cells
survived in vitro in response to CD40L than normal B cells
(Fig. 4, C and D). IL-10 had no effect on apoptosis (Fig. 4 C)
but modestly increased the recovery of viable cells in cultures
of normal, but not STAT3MUT, naive B cells (Fig. 4 D).
IL-21 reduced apoptosis and improved survival of both
control and STAT3MUT B cells (Fig. 4, C and D). Thus,
STAT3MUT B cells have an intrinsic defect in survival irrespective of the mode of in vitro stimulation. Furthermore,
IL-10 and IL-21 differ in their abilities and mechanisms to
support the survival of in vitro–cultured B cells, with the
effect of IL-10 but not IL-21 being STAT3 dependent.
Several cytokines regulate expression of their cognate receptor. Thus, it was possible that reduced function of IL-10
and IL-21 on human naive STAT3MUT B cells reflected differences in expression of their receptors. However, naive B cells
from healthy controls and STAT3MUT patients displayed comparable levels of IL-10R and IL-21R (Fig. 4, E and F). Thus,
the reduced responses of STAT3MUT B cells to the stimulatory effects of IL-21 and IL-10 reflect impaired STAT3dependent signaling rather than reduced expression of
cytokine receptors.
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sequences from STAT3MUT memory B cells were mutated,
resulting in a mean of 3 ± 1.33 mutations/sequence (Fig. 5, F
and G). Restricting analysis to only mutated sequences revealed that the load of mutations was comparable to normal
memory B cells (i.e., 5.4 ± 2.2 mutations/sequence; n = 13).
Thus, although fewer memory B cells from AD-HIES patients expressed mutated Ig V region genes, SHM can occur at
a normal rate. This is consistent with intact expression of
AICDA and isotype switching in STAT3MUT B cells.
STAT3 plays a nonredundant role in mediating
the differentiation of human naive B cells into ISCs
IL-10 and IL-21 can induce Ig secretion from CD40L-stimulated
naive B cells, with IL-21 being 10–100 times more efficient than

IL-10 (Pène et al., 2004; Bryant et al., 2007; Ettinger et al., 2008).
For this reason, we next examined the consequences of STAT3
mutations on the differentiation of naive B cells into ISCs in
response to these cytokines. CD40L induced few if any normal naive B cells to differentiate into ISCs (Fig. 6 A). However, in the presence of CD40L/IL-21, 10% became ISCs as
determined by acquisition of a CD38hiCD27hi phenotype
(Fig. 6 A), a differentiation event that correlates with commitment of in vivo– and in vitro–activated human B cells to the
PC lineage (Ellyard et al., 2004; Avery et al., 2005). In complete contrast, STAT3MUT naive B cells failed to generate ISCs
after stimulation with CD40L/IL-21 (Fig. 6 B).
Differentiation into ISCs is also linked to cell division
(Hodgkin et al., 1996; Tangye et al., 2003; Bryant et al.,
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Figure 6. STAT3 but not STAT1 is absolutely required for IL-21–induced differentiation of human naive B cells into ISCs. (A–C) Naive
B cells from control donors (A) or STAT3MUT patients (B) were labeled with CFSE and cultured with CD40L alone or together with IL-21. After 5 d, the
percentage of CD38hiCD27hi cells was determined. (C) Percentage of CD38hiCD27hi cells (mean ± SEM; n = 5) generated per division from control and
STAT3MUT naive B cells stimulated with CD40L/IL-21. (D–G) Naive B cells from healthy controls (D–F: n = 12; G: n = 5), STAT3MUT patients (D–F: n = 7; G:
n = 5), or STAT1MUT patients (n = 4) were cultured with CD40L alone or together with IL-21 (D–F) or CpG (G). The levels of secreted IgM (D and G), IgG
(E), and IgA (F) were determined by ELISA after 12 d. Each symbol represents Ig secretion by naive B cells from an individual normal donor or patient;
the horizontal bars represent means. (H–K) Naive B cells from healthy controls or STAT3MUT or STAT1MUT patients were cultured with CD40L alone (40L)
or together with IL-21 (+IL21) for 5 d. Expression of PAX5 (H), PRDM1 (I), XBP1 (J), and BCL6 (K) was determined by quantitative PCR. The results are
means ± SEM (control: n = 12; STAT3MUT: n = 7; or STAT1MUT: n = 3 experiments).
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Table I.

The failure of STAT3MUT naive B cells to differentiate
into ISCs in response to IL-21 or IL-10 is caused
by an inability to undergo the requisite molecular changes
for commitment to the PC lineage
Commitment of B cells to the PC lineage involves the coordinated actions of several transcription factors. It is initiated
by the loss of PAX5 (Kallies et al., 2007), followed by induction of BLIMP-1 and XBP-1, which are required for repression of the “B cell program” and enforcement of the “PC
program” of gene expression (Kallies et al., 2007; Tangye and
Tarlinton, 2009). To elucidate a molecular mechanism for
the inability of STAT3MUT naive B cells to become ISCs, we
assessed changes in the expression of PAX5, PRDM1 (encoding
BLIMP-1), and XBP1 in activated B cells by Q-PCR. Expression of PAX5 was reduced 3-fold, whereas PRDM1
and XBP1 were increased 2–10-fold in normal naive B cells
stimulated with CD40L/IL-21 compared with the expression
by B cells cultured with CD40L alone (Fig. 6, H–J). In contrast,
STAT3MUT B cells only modestly down-regulated PAX5 but
completely failed to acquire PRDM1 and XBP1 after culture
with CD40L/IL-21 (Fig. 6, H–J), demonstrating an inability
to undergo the transcriptional changes necessary for the generation of ISCs. Similar results were observed for normal and
STAT3MUT B cells cultured with IL-10 (Fig. S2, D and E). In
complete contrast to STAT3MUT B cells, IL-21 caused naive
STAT1MUT B cells to down-regulate PAX5 and increase
PRDM1 and XBP1 to a comparable extent as normal naive
B cells (Fig. 6, H–J), confirming further that STAT1 is dispensable for this process.
Memory B cell development largely occurs within
germinal centers (GCs; Tangye and Tarlinton, 2009). The
paucity of functional memory B cells in STAT3MUT patients
(Fig. 2, B and C) together with the finding that 50% of
STAT3MUT memory B cells express unmutated Ig V region
genes (Fig. 5, F and G) were suggestive of suboptimal GC
formation in cases of STAT3 mutations. BCL-6 is required
for GC formation in vivo (Tangye and Tarlinton, 2009) and

Impaired Ig secretion by STAT3MUT naive B cells in response to IL-10 and IL-21
Ig secretion
IgM
CD40L

Control
(n = 12)
STAT3MUT
(n = 7)
HIES STAT3WT
(n = 4)
STAT1MUT
(n = 4)

ng/ml
30 ± 10

+IL-21

+IL-10

+CpG

ng/ml
ng/ml
ng/ml
30,646 ± 5,344 640 ± 213 3,223 ± 1,023

33 ± 15

299 ± 168

25 ± 13

4,125 ± 955

45 ± 43

IgG

47 ± 20
ND

2,382 ± 546
ND

20,706 ± 7,569 715 ± 555 5,314 ± 3,399

CD40L

+IL-21

IgA
+IL-10

CD40L

+IL-21

+IL-10

ng/ml
<0.1

ng/ml
ng/ml
538 ± 193 3.8 ± 2.5

ng/ml
<0.1

ng/ml
ng/ml
3,750 ± 1,440 117 ± 81

<0.1

4.9 ± 1.6

<0.1

<0.1

1.8 ± 1.7

7.5 ± 7.5

<0.1

113 ± 67

ND

<0.1

785 ± 484

ND

<0.1

214 ± 114

ND

<0.1

432 ± 275

ND

Naive B cells from the indicated groups were cultured (10 x 103 cells/well/200 µl) with CD40L alone or together with IL-2, IL-10, or CpG. Ig secretion was measured after
10–12 d. The values are means ± SEM for the indicated number of donors with the exception of cultures of naive B cells from healthy donors or STAT3MUT patients stimulated
with CD40L/IL-10 or CD40L/CpG (n = 5) and STAT1MUT patients stimulated with CD40L/IL-10 (n = 2). ND, not done.
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2007). Although the frequency of normal naive B cells that
became CD38hiCD27hi in response to CD40L/IL-21 increased with division, STAT3MUT naive B cells failed to generate any ISCs irrespective of division history (Fig. 6 C).
Secretion of IgM by normal naive B cells stimulated
with CD40L/IL-21 is increased 1,000-fold over that induced by CD40L alone, whereas CD40L/IL-21 induced
these cells to secrete substantial amounts of IgG and IgA
(Table I; and Fig. 6, D–F). Consistent with the inability of
STAT3MUT naive B cells to differentiate into phenotypic
ISCs in response to CD40L/IL-21, their Ig secretion was
100–1,000-fold lower than that of corresponding normal
naive B cells (Table I; Fig. 6, D–F; and Fig. S3). STAT3MUT
naive B cells were also refractory to the effects of IL-10
(Table I). These findings were specific for naive B cells
from patients with STAT3 mutations, because there was
no significant difference in secretion of IgM, IgG, and IgA
by STAT1MUT (n = 4) and normal naive B cells in response
to CD40L/IL-21 (Table I; Fig. 6, D–F; and Table S3).
Similarly, naive B cells from individuals with high serum
IgE levels but WT STAT3 alleles (n = 4) secreted 10–200fold more Ig in response to CD40L/IL-21 than STAT3MUT
naive B cells (Table I), whereas CD40L/IL-21 induced normal Ig production by B cells from CVID patients (n = 11;
Fig. S3).
The inability of STAT3MUT naive B cells to become
ISCs in vitro in response to CD40L plus IL-10 or IL-21
was not caused by a general defect in Ig secretion, because
they produced normal levels of IgM in response to CD40L/
CpG, which increases IgM secretion induced by CD40L
alone by 50–100-fold (Fig. 6 G and Table I). Thus, unlike
isotype switching, STAT3 is absolutely required for IL-10– and
IL-21–mediated differentiation of naive B cells into ISCs
in vitro. Furthermore, because the response of STAT1MUT
B cells was normal, STAT1 is unlikely to make a major
contribution to this process, highlighting the necessary role
of STAT3.

Published January 4, 2010

can be induced in B cells by IL-21 (Ettinger et al., 2008).
Thus, we also examined BCL6 expression. IL-21 induced
substantial and comparable expression of BCL6 in CD40Lstimulated naive normal and STAT1MUT B cells. Although
IL-21 could induce BCL6 in STAT3MUT naive B cells, it was
10-fold less than that observed for normal and STAT1MUT
naive B cells (Fig. 6 K). Unlike IL-21, IL-10 did not induce
BCL6 in naive B cells (Fig. S2, D and E). Thus, the inability
to generate a sufficient pool of memory B cells in AD-HIES
may result from inefficient GC reactions.
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DISCUSSION
Although it has been appreciated for many years that cytokines can activate specific JAK–STAT signaling pathways in
B cells (Leonard, 2001; Murray, 2007), contributions of individual STATs to the development and effector function of
primary human B cells have not been established. IL-21 has
emerged as a key cytokine for establishing, maintaining, and
regulating the quality of Ab responses (Ozaki et al., 2002;
Pène et al., 2004; Bryant et al., 2007; Avery et al., 2008a,b;
Ettinger et al., 2008; Nurieva et al., 2008; Vogelzang et al.,
2008). IL-10 can also induce modest isotype switching and Ig
secretion from human B cells (Rousset et al., 1992; Brière
et al., 1994; Bryant et al., 2007). Our detailed analysis of
IL-10– and IL-21–mediated signaling in human naive B cells
demonstrated that although these cytokines predominantly
activate STAT1 and STAT3, B cell–intrinsic STAT3 is necessary and sufficient, whereas STAT1 is dispensable, for their establishment of long-lived, protective Ag-specific Ab responses.
Intact signaling through STAT3 is required to generate
the memory B cell pool (Fig. 7 B). In contrast, STAT1MUT
patients could generate normal numbers of memory B cells.
Studies of female carriers of X-linked severe combined immuno
deficiency indicated that naive B cells expressed both the
WT and mutant alleles of IL2RG/common  chain (c),
whereas memory B cells expressed only the WT allele (Conley
et al., 1988). This suggested that although signals through c
were dispensable for B cell development, they were necessary
for the generation of memory B cells (Conley et al., 1988). In
light of the findings that memory B cells are dramatically reduced in STAT3MUT patients, that IL-21 activates STAT3,
and that c is a component of the IL-21R (Asao et al., 2001;
Habib et al., 2002), we propose that IL-21 is a major contributor
to memory B cell formation and that this occurs through a
c/STAT3-dependent mechanism.
Although IL-21 activates both STAT1 and STAT3, the
consequences of DN mutations in STAT3, which reduce
function by 75%, are much more severe than STAT1 deficiency. Such reduced STAT3 function completely abolished
IL-21–mediated maturation of naive B cells into ISCs in vitro
(Fig. 7 A). In contrast, these processes were intact in STAT1MUT
B cells. These findings mirrored the impaired generation of
Ag-specific Ab responses noted in AD-HIES patients (Dreskin
et al., 1985; Leung et al., 1988; Sheerin and Buckley, 1991)
and the intact Ab responses in cases of STAT1 deficiency after
standard vaccinations or natural infection (Chapgier et al.,

2006a,b). Our results complement a recent study that demonstrated overexpression of STAT3 in human B cells induced
PC differentiation (Diehl et al., 2008), and therefore highlight a critical role for IL-21 and STAT3 in initiating and/or
maintaining serological immunity by generating Ag-specific
effector B cells from naive precursors in vivo. Our data also
suggest that IL-10 may contribute to this process. However,
given the differences in the magnitude of the responses induced by IL-10 and IL-21, the effect of IL-10 in vivo is likely
to be proportionally less than IL-21. IL-6 also activates STAT3
(Leonard, 2001) and supports Ig secretion by human PCs via
their heightened expression of the IL-6R (Ellyard et al., 2004;
Good et al., 2006; Ettinger et al., 2008). Thus, it is plausible
that IL-6 also contributes to STAT3-mediated regulation of
human B cell function in vivo.
Induction of AICDA and isotype switching could occur
despite mutations in STAT1 or STAT3, implying that (a) isotype switching is either mediated by residual STAT3 function
in STAT3MUT B cells, (b) there is functional redundancy between STAT1 and STAT3, or (c) isotype switching is independent of both STAT1 and STAT3 and involves pathways
such as Akt or mitogen-activated protein kinase (Fig. 7 A;
Zeng et al., 2007). Irrespective of the mechanism, it is clear that
Ig isotype switching is unaffected by STAT3 deficiency, which
contrasts with the dependency of the generation of memory
B cells and PCs on intact STAT3 function (Fig. 7, A and B).
Germline deletion of Stat3 in mice is embryonically lethal
(Akira, 1999; Tangye et al., 2009). However, insights into
STAT3 function in vivo have been provided by generating
Stat3flox/floxCd19cre mice (Fornek et al., 2006). Some aspects
of the phenotype of these mice are similar to STAT3MUT
patients, as both have normal levels of total serum IgM, IgG,
and IgA but a paucity of Ag-specific Ab (Dreskin et al., 1985;
Leung et al., 1988; Sheerin and Buckley, 1991; Fornek et al.,
2006). In Stat3flox/floxCd19cre mice, this resulted from an inability to generate Ag-specific IgG-secreting PCs (Fornek et al.,
2006). Interestingly, Il-21r-deficient mice also have a phenotype that resembles Stat3flox/floxCd19cre mice and STAT3MUT
humans: normal levels of serum IgM, IgA, and IgG (although
IgG1 is variably reduced under some experimental conditions) but impressive reductions in Ag-specific serum IgG1
titers and splenic PCs (Ozaki et al., 2002). It was unclear
from this study (Ozaki et al., 2002) whether the humoral immune defect resulted from an intrinsic B cell defect and/or an
extrinsic defect because of impaired generation of T follicular
helper cells (Nurieva et al., 2008; Vogelzang et al., 2008). By
using a well-established model of B cell differentiation
(Brink et al., 2008), we found that the Ag-specific (i.e., hen
egg lysozyme) response of IL-21R–deficient B cells was drastically diminished compared with WT B cells, as indicated by
a 10–20-fold reduction in the production of hen egg lysozyme–specific PCs and IgM and IgG (Fig. S4, A and B). This
analysis of in vivo responses of Il21r/ B cells strongly suggests that the key cytokine acting upstream of STAT3 in
mouse B cells required for intact humoral immune responses
to TD Ag is IL-21. Together with our in vitro analysis of
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STAT3MUT human B cells, this is further evidence of a pivotal
role of the IL-21R–STAT3 axis in regulating humoral immu
nity to TD Ag in humans.
Despite these similarities between Stat3flox/floxCd19cre mice
and STAT3MUT patients, the latter also have reductions in the
numbers of circulating memory B cells, as well as the levels of
serum and salivary Ag-specific IgA (Dreskin et al., 1985),
whereas Stat3flox/floxCd19cre B cells could apparently produce
Ag-specific IgM and IgA and generate IgG+ memory B cells
(Fornek et al., 2006). One explanation for these differences is
that STAT3 deficiency has a more dramatic effect on human
compared with mouse B cells, which is reminiscent of more
severe phenotypes in humans with mutations in TYK2, BTK,
and BLNK compared with gene-targeted mice (Conley
et al., 2000; Minegishi et al., 2006). Alternatively, these differences may reflect the fact that all cells are STAT3 deficient

in AD-HIES, whereas in Stat3flox/floxCd19cre mice, only the
B cells lack STAT3. Thus, B cell help afforded by other cells
(CD4+ T cells) may also be impaired in STAT3MUT patients,
and this may manifest as a more severe defect in humoral
immunity in humans compared with mice.
The mechanism underlying impaired humoral immune
responses in STAT3MUT patients was an inability of their
B cells to activate the molecular machinery necessary for the
generation of ISCs from naive precursors in response to
IL-21 (Fig. 7 A). It is important to appreciate that STAT3MUT
patients do not lack PCs, as they have normal serum Ig levels,
and we could detect PCs in their lymphoid tissues (Fig. S5 A).
Thus, STAT3-dependent signaling is crucial for generating
effective Ag-specific Ab responses but not for maintaining
total serum Ig levels, which are presumably regulated by
STAT3-independent pathways such as those downstream of
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Figure 7. Differential requirement for STAT3 in regulating human B cell differentiation. Naive B cells can be induced to undergo proliferation, isotype
switching, and differentiation to the PC lineage via distinct pathways: (A) in vitro in response to TD stimulation (CD40L plus IL-21), (B) in vivo in response to
TD Ag and subsequent GC formation, and (C) in response to TD and T cell–independent stimuli in the form of CD40L and/or BAFF, APRIL, TLR ligands (e.g.,
viral double-stranded RNA [TLR3] or CpG [TLR9]), and cytokines. Mutations in STAT3 differentially affect each of these pathways (red text). By impairing the
up-regulation of PRDM1 (BLIMP-1) and XBP1, STAT3MUT B cells are unable to become ISCs in vitro; in contrast, induction of AICDA and Ig isotype switching are
intact (A). Although GCs can be detected in STAT3MUT patients, the output of memory B cells and efficient PCs, as assessed by reduced numbers of CD27+ B cells
and serum Ab titers against specific Ag, respectively, is impaired. This may result from reduced induction of BCL6 in response to IL-21. Ig production by STAT3MUT
B cells in response to STAT3-independent TD and T cell–independent pathways is intact; this may explain the normal serum Ig levels in these patients (C).
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naive B cells into IgE+ B cells (Harris et al., 1999). Interestingly, Bcl6-deficient mice fail to form GCs yet have elevated
levels of IgE because of aberrant generation of IgE-PCs
resulting from dysregulated IL-4 secretion and signaling via
STAT6 (Harris et al., 1999; Tangye and Tarlinton, 2009).
Thus, reduced expression of BCL6 but not AICDA in
STAT3MUT B cells and potentially inefficient GC reactions
in STAT3MUT patients may remove a regulatory circuit that
ordinarily controls IL-4/STAT6–induced IgE production,
thereby manifesting as hyper-IgE.
Overall, our data identify STAT3 as the key signaling
component downstream of the IL-21R necessary for the
generation of human memory B cells and ISCs, and thus,
humoral immune responses. These findings identify a pathway that results in a clinical phenotype of specific Ab deficiency, and implicate B cell–intrinsic defects in components
of the IL-21R–STAT3 pathway as candidates underlying impaired Ab formation in other immunodeficient conditions.
MATERIALS AND METHODS
mAbs and reagents. The following mAbs were used: FITC–anti-CD20
and allophycocyanin (APC)–anti-CD10 (BD); biotinylated anti–human
IgM, IgG, and IgA; PE–anti-CD27 and anti–phospho-STAT3; APC–antiIgG and anti-CD38; streptavidin-PerCp; PE–anti–IL-10R, Alexa Fluor
488–anti–phospho-STAT5, Alexa Fluor 647–anti–phospho-STAT1, and
anti–phospho-STAT6 (BD); biotin– and APC–anti-CD27 (eBioscience);
and PE–anti–IL-21R (R&D Systems).
Human blood and tissue samples. Buffy coats from healthy donors and
spleens from organ donors were provided by the Australian Red Cross Blood
Service. PB was collected from patients with STAT3 mutations, patients
with mutations in STAT1, or patients with CVID or with elevated levels of
serum IgE but WT STAT3 alleles. The mutations and clinical details of the
STAT1MUT patients (Dupuis et al., 2001; Chapgier et al., 2006a,b; Chapgier
et al., 2009), some of the AD-HIES patients (patients 1–5), and the STAT3
genotyping protocol (Ma et al., 2008) have been previously described; those
of AD-HIES patients 6–10 are listed in Table S1. All human experiments
were approved by jurisdictional ethics committees in Canberra, Sydney,
Melbourne, Adelaide, Brisbane, and Perth, as well as by the institutional
review boards of the Necker Medical School and the Rockefeller University.
B cell phenotyping and isolation. PBMCs were incubated with
mAb to CD20, CD10, and CD27. The frequencies of transitional
(CD20+CD10+CD27), naive (CD20+CD10CD27), and memory
(CD20+CD10CD27+) B cells were then determined (Wardemann et al.,
2003; Avery et al., 2008b). Expression of Ig isotypes on memory B cells and
cytokine receptors on naive B cells was determined as previously described
(Ma et al., 2005; Good et al., 2006; Ma et al., 2006; Avery et al., 2008b).
B cells were isolated with a Negative Isolation kit (Invitrogen). Naive PB
B cells were purified by labeling total B cells with mAbs against CD20, CD27,
and IgG and sorting CD20+CD27IgG cells (FACSAria; BD). The purity
of the recovered naive population was typically >98%.
Expression of phospho-STATs. Human splenic B cells were cultured
with CD40L (Tangye et al., 2002) plus F(ab)2 fragments of goat anti–human
Ig (Jackson ImmunoResearch Laboratories, Inc.) for 24 h, washed, and
recultured in the absence or presence of 100 ng/ml IL-21 for different
periods of time before being fixed, permeabilized, and labeled with anti–
phospho-STAT1, -STAT3, -STAT5, and -STAT6 mAbs (Avery et al.,
2008b). EBV-LCLs established from normal healthy donors and STAT3MUT
and STAT1MUT patients were stimulated with or without IL-10 or IL-21 for
30 min, and expression of phospho-STATs was then determined.
STAT3 deficiency impairs B cell differentiation | Avery et al.
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BCR, CD40, BAFF-R/TACI, Toll-like receptors (TLRs),
and specific cytokine receptors (Fig. 7 C). This is supported
by the ability of human STAT3MUT B cells to isotype switch
to IL-4 and/or IL-21, and Ig secretion to CpG, and the wellestablished roles of TLRs and BAFF/APRIL, together with
IL-4 or IL-15, in directing Ig isotype switching and secretion
by human B cells (Litinskiy et al., 2002; Xu et al., 2008).
In contrast to the functional Ab deficit, the explanation
for the memory B cell deficiency in STAT3MUT patients is
less clear. Most memory B cells are generated in GCs (Tangye
and Tarlinton, 2009). Because Stat3flox/floxCd19cre mice can
form GCs in response to TD Ag (Fornek et al., 2006) and
GC-like structures were detected in the lymph node of
STAT3MUT patients (Fig. S5 B), a lack of GCs cannot explain
the paucity of memory B cells in these patients. One possibility is that STAT3 is required for the survival of memory
B cells generated from a GC, which is consistent with a
requirement for STAT3 in protecting mouse B cells from
apoptosis in vivo (Otero et al., 2006), and that STAT3MUT
B cells appeared to be less responsive to the prosurvival effects
of IL-10 than control B cells. Alternatively, STAT3 mutations may result in qualitatively inefficient GC reactions that
are unable to generate memory B cells and only yield lowaffinity PCs (Fig. 7 B). This is supported by our findings that
STAT3MUT memory B cells have a reduced load of SHM,
Ag-specific IgG produced by STAT3MUT patients was of
reduced affinity, and expression of BCL6 by STAT3MUT naive
B cells in response to IL-21 in vitro was only 10% of that
observed for normal naive B cells.
Although STAT3MUT patients have reduced levels of
Ag-specific IgG and IgA, they have aberrantly high IgE
(Grimbacher et al., 2005). Several studies have reported that
the IgE in AD-HIES patients is Ag specific (Schopfer et al.,
1979; Berger et al., 1980). Although our findings do not
provide a conclusive explanation for the high level of serum
IgE conferred by STAT3 mutations, they point to fundamental differences in the STAT3 dependence of production/
maintenance of Ag-specific IgM, IgG, and IgA compared
with Ag-specific IgE. Similarly, our findings indicate that
STAT3 is crucial for generating high-affinity Ag-specific Ab
but not for maintaining total serum Ig (Fig. 7). We infer
from this that STAT3 is important for the formation and/or
survival of memory B cells and PC-producing IgM, IgG,
and IgA, and our data represent evidence of the importance
of IL-21 signaling via STAT3 for the differentiation of GC
B cells into these effector cells. The corollary is that there is
a significant contribution to IgE responses from pathways
outside the GC, which are STAT3 independent. Indeed,
Erazo et al. (2007) noted that although IgG+ PCs arise from
GCs, IgE+ PCs were excluded from GCs and localized to
extrafollicular areas. Furthermore, IgE variable region genes
exhibit significantly fewer somatic mutations than IgG variable region genes (Dahlke et al., 2006), which suggests that
IgE+ B cells are not selected within GCs. These observations
are consistent with the ability of BCL-6 (expressed by GC
B cells) to inhibit IL-4/STAT6–mediated differentiation of
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Detecting Ag-specific B cells. Total B cells (1–2 × 105 cells/400 µl) were
cultured with CD40L, 1 µg/ml CpG 2006 (Sigma-Aldrich), 0.01% SAC
(EMD), 100 U/ml IL-10 (provided by R. de Waal Malefyt, DNAX
Research, Palo Alto, CA), and 50 ng/ml IL-21 (PeproTech). After 4 d, the
cells were washed and recultured (1–2 × 105 cells/500 µl) with CD40L,
CpG, IL-10, and IL-21 for a further 3 d. The activated B cells were then incubated in ELISPOT plates (Millipore) precoated with goat anti–human IgM
and IgG antisera (SouthernBiotech) or tetanus toxoid (Sigma-Aldrich). The
percentage of cells secreting polyclonal IgM, IgG, or tetanus-specific IgG
was determined (Tangye et al., 2003). Levels of antitetanus IgG in culture
supernatants and serum were determined by performing titrations in ELISA
plates precoated with tetanus and then detecting bound IgG.

Sequence analysis of Ig VH genes. The VH5 genes were amplified from
cDNA isolated from sort-purified naive and memory B cells by nested PCR
using Pfu DNA polymerase (Ellyard et al., 2004; Ma et al., 2006). Nucleotide
sequences were analyzed using the Sequencher program (Gene Codes) and
compared with germline Ig VH5 region genes (available from IMGT/
GENE-DB under accession nos. M99686 and M18806). Ambiguous
sequences were excluded from the analysis.
Quantitative PCR for expression of B cell transcription factors. Naive
B cells isolated from normal donors or STAT3MUT or STAT1MUT patients
were cultured with CD40L alone or together with IL-10 or IL-21
for 5 d. Expression of BCL6 (forward, 5-GAGCTCTGTTGATTCTTA
GAACTGG-3; reverse, 5-GCCTTGCTTCACAGTCCAA-3), AICDA
(forward, 5-GACTTTGGTTATCTTCGCAATAAGA-3; reverse, 5-AGG
TCCCAGTCCGAGATGTA-3), PAX5 (forward, 5-ACGCTGACAGG
GATGGTG-3; reverse, 5-CCTCCAGGAGTCGTTGTACG-3), PRDM1/
BLIMP-1 (forward, 5-AACGTGTGGGTACGACCTTG-3; reverse, 5-ATT
TTCATGGTCCCCTTGGT-3), and XBP1 (forward, 5-CCGCAGCACTCAGACTACG-3; reverse, 5-TGCCCAACAGGATATCAGACT-3) was
then determined by real-time PCR using the LightCycler 480 Probe
Master Mix and System (Roche). All real-time PCR primers were from
Integrated DNA Technologies. All reactions were standardized to the expres
sion of GAPDH (forward, 5-CTCTGCTCCTCCTGTTCGAC-3; reverse,
5-ACGACCAAATCCGTTGACTC-3).
Online supplemental material. Table S1 lists features of AD-HIES
patients 6–10 (patients 1–5 have been described previously; Ma et al., 2008).
Table S2 lists features of the patients with mutations in STAT1 used in
this study. Table S3 lists the level of statistical significance for Ig secretion by
STAT3MUT and STAT1MUT naive B cells relative to normal naive B cells.
Fig. S1 compares the effect of IL-10 and IL-21 on induction of phosphoSTATs in LCLs from normal donors and STAT3MUT and STAT1MUT patients.
Fig. S2 shows the effect of IL-10 on induction of IgG isotype switching and expression of AICDA, PAX5, PRDM1, and BCL6 by CD40LJEM VOL. 207, January 18, 2010
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